Implant could block opioid cravings for months
NCT ID NCT05382091
Summary
This study is testing the safety of a biodegradable implant that slowly releases naltrexone, a medication that blocks the effects of opioids. The implant is placed under the skin of the abdomen and is designed to help people with opioid addiction stay in recovery by preventing relapse for extended periods. Researchers will follow 250 participants for 60 weeks to monitor side effects and see how well the implant helps people avoid using opioids.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.